Publications by authors named "R Bonometti"

Article Synopsis
  • The study investigates the effectiveness of compression ultrasound (CUS) for diagnosing venous thromboembolism (VTE), particularly pulmonary embolism (PE) and deep vein thrombosis (DVT), in hospitalized patients presenting with respiratory issues.
  • Out of 263 patients, CUS identified DVT in 31 individuals, and a follow-up CT scan confirmed PE in 9 of them, revealing flaws in the Wells score's ability to accurately predict VTE risk.
  • The research suggests that routinely using CUS could enhance diagnostic accuracy for VTE in patients with dyspnea or respiratory failure admitted to internal medicine.
View Article and Find Full Text PDF

Multicentric Castleman disease (MCD) is a rare clinical entity characterized by a polyclonal lymphoid proliferation, leading to generalized lymphadenopathy, organomegaly and systemic symptoms. It has been reported in association with either other monoclonal or polyclonal lymphoid disorders, such as POEMS syndrome and immunoglobulin (Ig)G4-related disease. We present a patient showing a variant of MCD, sharing common features with POEMS syndrome and associated with the proliferation of IgG4-producing plasma cells.

View Article and Find Full Text PDF

Objective: This study evaluated the ability of mid-regional proadrenomedullin (MR-proADM) to identify disease severity in Coronavirus disease 2019 (COVID-19) patients in comparison to conventional inflammatory biomarkers and clinical scores.

Patients And Methods: In an observational trial, COVID-19 acute respiratory distress syndrome (ARDS) patients were enrolled. MR-proADM, C-reactive protein (CRP), procalcitonin (PCT) and lactic acid (LA) were measured in all patients at admission (T0), at 24 hours (T1) and in the third (T3) and fifth day (T5) of hospitalization.

View Article and Find Full Text PDF

Currently, few evidences have shown the possible involvement of autoimmunity in patients affected by coronavirus disease 2019 (COVID-19). In this study, we elucidate whether severe acute respiratory syndrome coronavirus disease 2 (SARS-CoV-2) stimulates autoantibody production and contributes to autoimmunity activation. We enrolled 40 adult patients (66.

View Article and Find Full Text PDF

Though the exact etiology of autoimmune diseases still remains not completely known, there are various factors which are known to contribute to be trigger of autoimmune diseases. Viral infection is known to be among the other. It is known as the infection from severe acute respiratory syndrome coronavirus (SARS-CoV) and Middle East respiratory syndrome coronavirus (MERS-CoV) can be an autoimmune trigger, so, we suppose that SARS-Coronavirus (SARS-CoV-2) could be as well.

View Article and Find Full Text PDF